Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil
Local biotech company Resverlogix has been developing an antiviral and anti-inflammatory oral treatment
Source: edmontonjournal.com
Stay updated with breaking news from Christopher Sarsons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Local biotech company Resverlogix has been developing an antiviral and anti-inflammatory oral treatment
Watch this page throughout the day for updates on COVID-19 in Calgary.